PRELUDE CAPITAL MANAGEMENT, LLC - ALBANY MOLECULAR RESH INC ownership

ALBANY MOLECULAR RESH INC's ticker is and the CUSIP is 012423AB5. A total of 21 filers reported holding ALBANY MOLECULAR RESH INC in Q3 2016. The put-call ratio across all filers is - and the average weighting 1.2%.

Quarter-by-quarter ownership
PRELUDE CAPITAL MANAGEMENT, LLC ownership history of ALBANY MOLECULAR RESH INC
ValueSharesWeighting
Q2 2016$566,000
-46.2%
550,000
-42.1%
0.08%
-46.3%
Q1 2016$1,053,000
+56.0%
950,000
+90.0%
0.15%
+40.0%
Q4 2015$675,000500,0000.10%
Other shareholders
ALBANY MOLECULAR RESH INC shareholders Q3 2016
NameSharesValueWeighting ↓
Birch Grove Capital LP 8,500,000$10,083,0009.46%
Context Capital Management, LLC 6,575,000$7,787,0007.57%
Mohican Financial Management, LLC 4,500,000$5,302,0005.80%
Verition Fund Management LLC 3,000,000$3,549,0000.38%
BASSO CAPITAL MANAGEMENT, L.P. 2,150,000$2,534,0000.37%
OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) 20,000,000$23,642,000,0000.35%
SSI INVESTMENT MANAGEMENT LLC 3,364,000$3,964,0000.35%
WOLVERINE ASSET MANAGEMENT LLC 14,903,000$17,636,0000.26%
CSS LLC/IL 3,700,000$4,370,0000.21%
PALISADE CAPITAL MANAGEMENT, LP 4,582,000$5,424,0000.19%
View complete list of ALBANY MOLECULAR RESH INC shareholders